Loading…
The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production
Antivenom production against venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participa...
Saved in:
Published in: | Toxins 2023-09, Vol.15 (10), p.589 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273 |
container_end_page | |
container_issue | 10 |
container_start_page | 589 |
container_title | Toxins |
container_volume | 15 |
creator | Miranda, Ana Luísa Soares de Antunes, Bruno Cesar Minozzo, João Carlos Lima, Sabrina de Almeida Botelho, Ana Flávia Machado Campos, Marco Túlio Gomes Chávez-Olórtegui, Carlos Soto-Blanco, Benito |
description | Antivenom production against
venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production. |
doi_str_mv | 10.3390/toxins15100589 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a5936d33c0584bc7b25bb11666c1984e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A772533890</galeid><doaj_id>oai_doaj_org_article_a5936d33c0584bc7b25bb11666c1984e</doaj_id><sourcerecordid>A772533890</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273</originalsourceid><addsrcrecordid>eNptkk1vGyEQhldVqyZyc-2xQuqlF6cDLCx7qiIrrSNZaqUkZ8TyYWPtLi6wkfPvi5M0javAgWF45mVmNFX1EcM5pS18zWHvx4QZBmCifVOdEmjInHOG376wT6qzlLZQFqW4xc376oQ2QghO4LQyNxuLllb1eYOus8pTQsGhZYjJJnSbrEEuRKQyWlmVMrr2e7QIw6632aLFve7tA78K-5C07b1GF2P2d3YMA_oVg5l09mH8UL1zqk_27OmcVbffL28Wy_nq54-rxcVqrhk0ed7yrhPO1QoLymsKQIB0qsbCCUcxtKVkJkAwqgF3gA13hxsYYThzhjR0Vl096pqgtnIX_aDivQzKywdHiGupYvYla6lYS7mhRYqJutNNR1jXYcw517gVtS1a3x61dlM3WKPtmKPqj0SPX0a_ketwJzHwkmvJclZ9eVKI4fdkU5aDPzSpV6MNU5JECMoaaDAp6Of_0G2Y4lh6daCIqIG39T9qrUoFfnShfKwPovKiaQijVLRQqPNXqLKNHbwOo3W--F8L0DGkFK17LhKDPMyZPJ6zEvDpZWue8b9TRf8AM0jLmg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2882840694</pqid></control><display><type>article</type><title>The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central(OpenAccess)</source><creator>Miranda, Ana Luísa Soares de ; Antunes, Bruno Cesar ; Minozzo, João Carlos ; Lima, Sabrina de Almeida ; Botelho, Ana Flávia Machado ; Campos, Marco Túlio Gomes ; Chávez-Olórtegui, Carlos ; Soto-Blanco, Benito</creator><creatorcontrib>Miranda, Ana Luísa Soares de ; Antunes, Bruno Cesar ; Minozzo, João Carlos ; Lima, Sabrina de Almeida ; Botelho, Ana Flávia Machado ; Campos, Marco Túlio Gomes ; Chávez-Olórtegui, Carlos ; Soto-Blanco, Benito</creatorcontrib><description>Antivenom production against
venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production.</description><identifier>ISSN: 2072-6651</identifier><identifier>EISSN: 2072-6651</identifier><identifier>DOI: 10.3390/toxins15100589</identifier><identifier>PMID: 37888620</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Abnormalities ; Abscesses ; Adjuvants, Immunologic ; Animal experimentation ; Animal welfare ; Animals ; Antigens ; antisera production ; Antivenins ; Antivenom ; brown spider ; Cardiac arrhythmia ; Clinical significance ; dermonecrosis ; Design and construction ; EKG ; Health aspects ; Health Status ; Heart ; Hematology ; Horses ; Immunization ; Immunoglobulins ; Inoculation ; Liver ; loxoscelism ; Lymphatic system ; Methods ; Pacemakers ; Physiology ; Renal function ; safety evaluation ; Sinuses ; Statistical significance ; Testing ; Venom</subject><ispartof>Toxins, 2023-09, Vol.15 (10), p.589</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273</cites><orcidid>0000-0001-6247-2255 ; 0000-0003-0341-114X ; 0000-0003-2521-1114 ; 0000-0003-3861-1838 ; 0000-0003-4837-9374</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2882840694/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2882840694?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37888620$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miranda, Ana Luísa Soares de</creatorcontrib><creatorcontrib>Antunes, Bruno Cesar</creatorcontrib><creatorcontrib>Minozzo, João Carlos</creatorcontrib><creatorcontrib>Lima, Sabrina de Almeida</creatorcontrib><creatorcontrib>Botelho, Ana Flávia Machado</creatorcontrib><creatorcontrib>Campos, Marco Túlio Gomes</creatorcontrib><creatorcontrib>Chávez-Olórtegui, Carlos</creatorcontrib><creatorcontrib>Soto-Blanco, Benito</creatorcontrib><title>The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production</title><title>Toxins</title><addtitle>Toxins (Basel)</addtitle><description>Antivenom production against
venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production.</description><subject>Abnormalities</subject><subject>Abscesses</subject><subject>Adjuvants, Immunologic</subject><subject>Animal experimentation</subject><subject>Animal welfare</subject><subject>Animals</subject><subject>Antigens</subject><subject>antisera production</subject><subject>Antivenins</subject><subject>Antivenom</subject><subject>brown spider</subject><subject>Cardiac arrhythmia</subject><subject>Clinical significance</subject><subject>dermonecrosis</subject><subject>Design and construction</subject><subject>EKG</subject><subject>Health aspects</subject><subject>Health Status</subject><subject>Heart</subject><subject>Hematology</subject><subject>Horses</subject><subject>Immunization</subject><subject>Immunoglobulins</subject><subject>Inoculation</subject><subject>Liver</subject><subject>loxoscelism</subject><subject>Lymphatic system</subject><subject>Methods</subject><subject>Pacemakers</subject><subject>Physiology</subject><subject>Renal function</subject><subject>safety evaluation</subject><subject>Sinuses</subject><subject>Statistical significance</subject><subject>Testing</subject><subject>Venom</subject><issn>2072-6651</issn><issn>2072-6651</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1vGyEQhldVqyZyc-2xQuqlF6cDLCx7qiIrrSNZaqUkZ8TyYWPtLi6wkfPvi5M0javAgWF45mVmNFX1EcM5pS18zWHvx4QZBmCifVOdEmjInHOG376wT6qzlLZQFqW4xc376oQ2QghO4LQyNxuLllb1eYOus8pTQsGhZYjJJnSbrEEuRKQyWlmVMrr2e7QIw6632aLFve7tA78K-5C07b1GF2P2d3YMA_oVg5l09mH8UL1zqk_27OmcVbffL28Wy_nq54-rxcVqrhk0ed7yrhPO1QoLymsKQIB0qsbCCUcxtKVkJkAwqgF3gA13hxsYYThzhjR0Vl096pqgtnIX_aDivQzKywdHiGupYvYla6lYS7mhRYqJutNNR1jXYcw517gVtS1a3x61dlM3WKPtmKPqj0SPX0a_ketwJzHwkmvJclZ9eVKI4fdkU5aDPzSpV6MNU5JECMoaaDAp6Of_0G2Y4lh6daCIqIG39T9qrUoFfnShfKwPovKiaQijVLRQqPNXqLKNHbwOo3W--F8L0DGkFK17LhKDPMyZPJ6zEvDpZWue8b9TRf8AM0jLmg</recordid><startdate>20230926</startdate><enddate>20230926</enddate><creator>Miranda, Ana Luísa Soares de</creator><creator>Antunes, Bruno Cesar</creator><creator>Minozzo, João Carlos</creator><creator>Lima, Sabrina de Almeida</creator><creator>Botelho, Ana Flávia Machado</creator><creator>Campos, Marco Túlio Gomes</creator><creator>Chávez-Olórtegui, Carlos</creator><creator>Soto-Blanco, Benito</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6247-2255</orcidid><orcidid>https://orcid.org/0000-0003-0341-114X</orcidid><orcidid>https://orcid.org/0000-0003-2521-1114</orcidid><orcidid>https://orcid.org/0000-0003-3861-1838</orcidid><orcidid>https://orcid.org/0000-0003-4837-9374</orcidid></search><sort><creationdate>20230926</creationdate><title>The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production</title><author>Miranda, Ana Luísa Soares de ; Antunes, Bruno Cesar ; Minozzo, João Carlos ; Lima, Sabrina de Almeida ; Botelho, Ana Flávia Machado ; Campos, Marco Túlio Gomes ; Chávez-Olórtegui, Carlos ; Soto-Blanco, Benito</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abnormalities</topic><topic>Abscesses</topic><topic>Adjuvants, Immunologic</topic><topic>Animal experimentation</topic><topic>Animal welfare</topic><topic>Animals</topic><topic>Antigens</topic><topic>antisera production</topic><topic>Antivenins</topic><topic>Antivenom</topic><topic>brown spider</topic><topic>Cardiac arrhythmia</topic><topic>Clinical significance</topic><topic>dermonecrosis</topic><topic>Design and construction</topic><topic>EKG</topic><topic>Health aspects</topic><topic>Health Status</topic><topic>Heart</topic><topic>Hematology</topic><topic>Horses</topic><topic>Immunization</topic><topic>Immunoglobulins</topic><topic>Inoculation</topic><topic>Liver</topic><topic>loxoscelism</topic><topic>Lymphatic system</topic><topic>Methods</topic><topic>Pacemakers</topic><topic>Physiology</topic><topic>Renal function</topic><topic>safety evaluation</topic><topic>Sinuses</topic><topic>Statistical significance</topic><topic>Testing</topic><topic>Venom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miranda, Ana Luísa Soares de</creatorcontrib><creatorcontrib>Antunes, Bruno Cesar</creatorcontrib><creatorcontrib>Minozzo, João Carlos</creatorcontrib><creatorcontrib>Lima, Sabrina de Almeida</creatorcontrib><creatorcontrib>Botelho, Ana Flávia Machado</creatorcontrib><creatorcontrib>Campos, Marco Túlio Gomes</creatorcontrib><creatorcontrib>Chávez-Olórtegui, Carlos</creatorcontrib><creatorcontrib>Soto-Blanco, Benito</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Toxins</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miranda, Ana Luísa Soares de</au><au>Antunes, Bruno Cesar</au><au>Minozzo, João Carlos</au><au>Lima, Sabrina de Almeida</au><au>Botelho, Ana Flávia Machado</au><au>Campos, Marco Túlio Gomes</au><au>Chávez-Olórtegui, Carlos</au><au>Soto-Blanco, Benito</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production</atitle><jtitle>Toxins</jtitle><addtitle>Toxins (Basel)</addtitle><date>2023-09-26</date><risdate>2023</risdate><volume>15</volume><issue>10</issue><spage>589</spage><pages>589-</pages><issn>2072-6651</issn><eissn>2072-6651</eissn><abstract>Antivenom production against
venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37888620</pmid><doi>10.3390/toxins15100589</doi><orcidid>https://orcid.org/0000-0001-6247-2255</orcidid><orcidid>https://orcid.org/0000-0003-0341-114X</orcidid><orcidid>https://orcid.org/0000-0003-2521-1114</orcidid><orcidid>https://orcid.org/0000-0003-3861-1838</orcidid><orcidid>https://orcid.org/0000-0003-4837-9374</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6651 |
ispartof | Toxins, 2023-09, Vol.15 (10), p.589 |
issn | 2072-6651 2072-6651 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_a5936d33c0584bc7b25bb11666c1984e |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central(OpenAccess) |
subjects | Abnormalities Abscesses Adjuvants, Immunologic Animal experimentation Animal welfare Animals Antigens antisera production Antivenins Antivenom brown spider Cardiac arrhythmia Clinical significance dermonecrosis Design and construction EKG Health aspects Health Status Heart Hematology Horses Immunization Immunoglobulins Inoculation Liver loxoscelism Lymphatic system Methods Pacemakers Physiology Renal function safety evaluation Sinuses Statistical significance Testing Venom |
title | The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A12%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Health%20Status%20of%20Horses%20Used%20for%20at%20Least%20Six%20Complete%20Cycles%20of%20Loxoscelic%20Antivenom%20Production&rft.jtitle=Toxins&rft.au=Miranda,%20Ana%20Lu%C3%ADsa%20Soares%20de&rft.date=2023-09-26&rft.volume=15&rft.issue=10&rft.spage=589&rft.pages=589-&rft.issn=2072-6651&rft.eissn=2072-6651&rft_id=info:doi/10.3390/toxins15100589&rft_dat=%3Cgale_doaj_%3EA772533890%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2882840694&rft_id=info:pmid/37888620&rft_galeid=A772533890&rfr_iscdi=true |